Category: Medical
-
Opinion: TrumpRx has a fundamental flaw
•
The Trump administration is preparing to launch TrumpRx.com, an initiative aimed at lowering drug costs by aggregating direct-to-consumer…
-
STAT+: Vertex’s CRISPR treatment for sickle cell disease hits unexpected roadblock
•
Vertex executives warned that Casgevy, its curative treatment for sickle cell disease, would be slow to reach patients.…
-
The FDA wants to rein in drug ads. On Super Bowl Sunday, it will be business as usual
•
The nation’s top drug regulator said he wants to do away with pharmaceutical ads that employ “dancing patients,…
-
STAT+: FTC settles lawsuit with Express Scripts over charges it manipulated insulin prices, impeded access
•
The Federal Trade Commission said Wednesday that it had settled a lawsuit against Express Scripts, one of the…
-
STAT+: Pfizer defends data on Metsera candidate
•
Want to stay on top of the science and politics driving biotech today? Sign up to get our biotech newsletter…
-
STAT+: Pharmalittle: We’re reading about worries over FDA voucher program, a new U.S. Novo exec, and more
•
Hello, everyone, and how are you today? We are doing just fine, thank you, especially since the middle…
-
STAT+: Novo Nordisk sees lower sales, profits as Wegovy faces growing competition
•
Novo Nordisk on Tuesday said it expects sales and profits to decline this year, as the maker of…
-
STAT+: Pfizer unveils data on Metsera drug
•
Want to stay on top of the science and politics driving biotech today? Sign up to get our biotech newsletter…
-
STAT+: Pharmalittle: We’re reading about a Pfizer obesity pill, Florida’s failed drug importation plan, and more
•
Top of the morning to you, and a fine one it is. Despite frigid temperatures and icy paths,…
-
STAT+: Pfizer moves forward with its hopes for a monthly obesity drug
•
Pfizer’s resurrection in the obesity market took its next step Tuesday. The pharma firm said that an experimental…
-
STAT+: As U.S. officials move to reduce animal testing in research, focus may shift to restrictions on imports
•
Over the past year, the Trump administration has moved to reduce reliance on animal testing in scientific research…
-
STAT+: A play takes on Novo’s myth and money
•
Want to stay on top of the science and politics driving biotech today? Sign up to get our biotech newsletter…
-
STAT+: Pharmalittle: We’re reading about obesity drug sales, India’s biopharma research push, and more
•
Good morning, everyone, and welcome to another working week. We hope the weekend respite was relaxing and invigorating,…
-
STAT+: Sanofi is reprimanded by a U.K. trade group for misleading claims about a Pfizer vaccine
•
Sanofi was criticized by a U.K. trade group for violating several voluntary codes and “bringing discredit” on the…
-
STAT+: Why Bristol Myers Squibb believes a decades-old drug can treat Alzheimer’s
•
The hunt for blockbuster drugs has sent pharmaceutical companies into llama farms, outer space, and the soils of…
-
STAT+: As its immunology work draws attention, Sanofi also pushes forward in rare disease
•
Sanofi’s Cerezyme has long been used as a treatment for Gaucher disease, a rare illness that can cause…
Recent Posts
- How March Madness foes can end UConn’s run through bracket
- Tournament bets: 12-over-5 upset pick and the 2-seed with clearest path to Elite Eight
- March Madness: Odds, spreads and totals for every men’s opening round games
- One Battle After Another’s big night: Key takeaways from the 2026 Oscars
- Liberia: LDEA Seizes Drugs Worth L$7.77 Million At Ganta Border – Guinean National Arrested
- Nigeria: Why I Didn’t Panic After Losing Power – Sanusi
- Liberia: Police Declare Jackson’s Home ‘Restricted’ As Crime Scene Reconstruction Continues in Wife’s Death Probe
- Liberia: NCD Launches Historic Nationwide Tour to Assess Needs of Persons With Disabilities
- Liberia: CDC Raises Concern Over Foya Border Tension and Accuses Government of Risking National Peace
- Nigeria: 2027 – Tinubu Directs His Campaign Group to Donate Rice to Nigerians for Ramadan, Lent
- Nigeria: Mining Dispute – Govt Accuses Jupiter Ltd of Smear Campaign Plot During Tinubu’s UK Visit
- Nigeria: Nigerian Govt Denies ‘British Lithium Project’ Seizure, Alleges Smear Campaign Ahead of Tinubu’s UK Visit
Social Media
Advertisement
